Knight Therapeutics Inc. (TSX:GUD)
5.62
0.00 (0.00%)
Feb 21, 2025, 4:00 PM EST
Knight Therapeutics Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Market Capitalization | 564 | 541 | 584 | 630 | 696 | 1,028 | Upgrade
|
Market Cap Growth | 25.12% | -7.35% | -7.29% | -9.50% | -32.33% | -6.41% | Upgrade
|
Enterprise Value | 446 | 455 | 466 | 510 | 337 | 321 | Upgrade
|
Last Close Price | 5.62 | 5.19 | 5.18 | 5.30 | 5.35 | 7.58 | Upgrade
|
PE Ratio | - | - | - | 40.16 | 16.54 | 70.82 | Upgrade
|
Forward PE | 165.29 | 79.24 | - | 82.43 | - | 48.90 | Upgrade
|
PS Ratio | 1.64 | 1.65 | 1.99 | 2.59 | 3.49 | 21.66 | Upgrade
|
PB Ratio | 0.73 | 0.72 | 0.71 | 0.75 | 0.78 | 1.12 | Upgrade
|
P/TBV Ratio | 1.46 | 1.43 | 1.44 | 1.51 | 1.07 | 1.87 | Upgrade
|
P/FCF Ratio | 11.18 | 15.45 | 13.86 | 15.44 | - | 229.12 | Upgrade
|
P/OCF Ratio | 11.36 | 15.05 | 12.97 | 14.11 | - | 223.69 | Upgrade
|
EV/Sales Ratio | 1.28 | 1.39 | 1.59 | 2.10 | 1.69 | 6.75 | Upgrade
|
EV/EBITDA Ratio | 7.43 | 8.55 | 11.38 | 15.73 | 113.34 | - | Upgrade
|
EV/EBIT Ratio | 43.39 | 71.47 | - | - | - | - | Upgrade
|
EV/FCF Ratio | 8.84 | 13.01 | 11.07 | 12.52 | - | 71.44 | Upgrade
|
Debt / Equity Ratio | 0.08 | 0.09 | 0.09 | 0.05 | 0.06 | 0.07 | Upgrade
|
Debt / EBITDA Ratio | 0.97 | 1.24 | 1.73 | 1.18 | 9.99 | - | Upgrade
|
Debt / FCF Ratio | 1.16 | 1.97 | 1.84 | 1.00 | - | 13.86 | Upgrade
|
Asset Turnover | 0.35 | 0.33 | 0.29 | 0.24 | 0.17 | 0.04 | Upgrade
|
Inventory Turnover | 1.59 | 1.90 | 1.89 | 1.99 | 1.85 | 0.57 | Upgrade
|
Quick Ratio | 2.33 | 2.35 | 2.08 | 2.16 | 4.28 | 1.50 | Upgrade
|
Current Ratio | 3.36 | 3.20 | 2.80 | 2.90 | 4.84 | 1.77 | Upgrade
|
Return on Equity (ROE) | -3.87% | -2.14% | -3.58% | 1.81% | 3.53% | 1.85% | Upgrade
|
Return on Assets (ROA) | 0.65% | 0.40% | -1.04% | -0.79% | -1.40% | -0.25% | Upgrade
|
Return on Capital (ROIC) | 0.74% | 0.46% | -1.19% | -0.88% | -1.71% | -0.29% | Upgrade
|
Return on Capital Employed (ROCE) | 1.22% | 0.77% | - | - | - | - | Upgrade
|
Earnings Yield | -5.45% | -3.11% | -5.12% | 2.49% | 6.05% | 1.41% | Upgrade
|
FCF Yield | 8.94% | 6.47% | 7.22% | 6.48% | -2.53% | 0.44% | Upgrade
|
Buyback Yield / Dilution | 7.23% | 6.46% | 7.73% | 5.65% | 5.82% | 2.19% | Upgrade
|
Total Shareholder Return | 7.23% | 6.46% | 7.73% | 5.65% | 5.82% | 2.19% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.